EDSA
Edesa Biotech, Inc.
Company overview
- Market capitalization
- $35.19M
- Employees
- 17
- Latest publication
- 2026-09-29
About Edesa Biotech, Inc.
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. It develops EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 3 clinical study to treat chronic allergic contact dermatitis. The company develops EB07, a monoclonal antibody, which is in a Phase 2 clinical study for the treatment of pulmonary fibrosis; and EB06, a human monoclonal antibody candidate that binds to chemokine ligand 10 (CXCL10) and inhibits the interaction of CXCL10 with its receptors, CXCR3A, and CXCR3B. It has a collaboration agreement with NovImmune SA to develop monoclonal antibodies targeting products containing toll-like receptor 4 and CXCL10 for therapeutic, prophylactic, and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic, prophylactic, and diagnostic uses in topical dermal and anorectal applications, as well as for the use in dermatologic and gastrointestinal conditions. The company was founded in 2015 and is headquartered in Markham, Canada.
Financial statements
Income Quarterly
| Metric | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 50,918USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 25,872USD | 25,459USD | 25,868USD | 25,787USD | 24,509USD | 43,109USD | 44,206USD | 51,415USD |
| Gross Profit | -25,872USD | -25,459USD | -25,868USD | -25,787USD | -24,509USD | -43,109USD | -44,206USD | -51,415USD |
| Research Development | 2,767,088USD | 1,124,727USD | 1,225,547USD | 939,067USD | 484,306USD | 1,019,818USD | 103,867USD | 897,305USD |
| Selling General Administrative | 1,529,906USD | 1,216,656USD | 1,244,701USD | 964,676USD | 1,154,580USD | 878,871USD | 900,529USD | 1,035,140USD |
| Total Operating Expenses | 4,271,122USD | 2,315,923USD | 2,444,380USD | 1,903,743USD | 1,638,886USD | 1,898,689USD | 1,004,396USD | 1,932,445USD |
| Operating Income | -4,296,994USD | -2,341,383USD | -2,470,248USD | -1,903,743USD | -1,638,886USD | -1,898,689USD | -1,004,396USD | -1,932,445USD |
| Interest Income | 639USD | 47USD | 55USD | 572USD | 265USD | 1,666USD | 16,491USD | 32,848USD |
| Net Interest Income | 639USD | 47USD | 55USD | 572USD | 265USD | 1,666USD | 16,491USD | 32,848USD |
| Income Before Tax | -4,217,532USD | -2,247,669USD | -2,228,358USD | -1,749,464USD | -1,589,648USD | -1,617,253USD | -962,051USD | -1,668,212USD |
| Income Tax Expense | 800USD | — | — | — | 800USD | — | — | 4USD |
| Tax Provision | 800USD | — | 0USD | 0USD | 800USD | — | 0USD | 0USD |
| Net Income | -4,218,332USD | -2,247,669USD | -2,228,358USD | -1,749,464USD | -1,590,448USD | -1,617,253USD | -962,051USD | -1,668,212USD |
| Net Income From Continuing Ops | -4,218,332USD | -2,247,669USD | -2,228,358USD | -1,749,464USD | -1,590,448USD | -1,617,253USD | -962,051USD | -1,668,212USD |
| Ebit | -4,296,994USD | -2,341,383USD | -2,223,098USD | -1,720,462USD | -1,586,618USD | -1,597,494USD | -962,050USD | -1,668,211USD |
| Ebitda | -4,271,122USD | -2,315,924USD | -2,197,230USD | -1,694,675USD | -1,562,109USD | -1,554,385USD | -917,844USD | -1,616,796USD |
| Depreciation And Amortization | 25,872USD | 25,459USD | 25,868USD | 25,787USD | 24,509USD | 43,109USD | 44,206USD | 51,415USD |
| Reconciled Depreciation | 25,872USD | 25,460USD | 25,868USD | 25,787USD | 24,509USD | 43,109USD | 44,206USD | 51,415USD |
| Total Other Income Expense Net | 79,462USD | 93,714USD | 241,890USD | 154,279USD | 49,238USD | 281,436USD | 42,345USD | 264,233USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 51,415USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 500USD | 328,801USD | 410,870USD | 211,849USD |
| Cost Of Revenue | 119,273USD | 186,049USD | 183,471USD | 118,188USD | 118,788USD | 17,601USD | 101,286USD | 445,320USD |
| Gross Profit | -119,273USD | -186,049USD | -183,471USD | -118,188USD | -118,788USD | 311,200USD | 309,584USD | -233,471USD |
| Research Development | 3,668,738USD | 2,881,967USD | 4,794,549USD | 13,335,334USD | 17,947,072USD | 3,329,451USD | 1,096,426USD | 2,087,402USD |
| Selling General Administrative | 4,242,828USD | 4,132,777USD | 4,428,209USD | 5,035,456USD | 5,734,260USD | 3,382,591USD | 2,045,296USD | 2,757,377USD |
| Total Operating Expenses | 7,792,293USD | 7,014,744USD | 9,222,758USD | 18,370,790USD | 23,681,332USD | 6,712,042USD | 3,141,722USD | 4,844,779USD |
| Operating Income | -7,911,566USD | -7,014,744USD | -9,222,758USD | -18,370,790USD | -23,681,332USD | -6,400,842USD | -2,832,138USD | -5,078,250USD |
| Interest Income | 2,558USD | 153,498USD | 289,846USD | 63,523USD | 11,165USD | 37,778USD | 55,400USD | 40,100USD |
| Net Interest Income | 2,558USD | 153,498USD | 289,846USD | 63,523USD | 11,165USD | 37,778USD | 56,840USD | — |
| Income Before Tax | -7,184,723USD | -6,169,245USD | -8,373,615USD | -17,548,124USD | -13,342,350USD | -6,363,430USD | -2,776,734USD | -5,038,149USD |
| Income Tax Expense | 800USD | 800USD | 800USD | 800USD | 800USD | 800USD | -55,404USD | 800USD |
| Tax Provision | 800USD | 800USD | 800USD | 800USD | 800USD | 800USD | 0USD | 800USD |
| Net Income | -7,185,523USD | -6,170,045USD | -8,374,415USD | -17,548,924USD | -13,343,150USD | -6,364,230USD | -2,721,330USD | -5,038,949USD |
| Net Income From Continuing Ops | -7,185,523USD | -6,170,045USD | -8,374,415USD | -17,548,924USD | -13,343,150USD | -6,364,230USD | -3,702,311USD | -1,536,556USD |
| Ebit | -7,184,724USD | -6,169,249USD | -9,222,758USD | -17,548,120USD | -13,342,348USD | -6,400,842USD | -2,833,731USD | -5,038,150USD |
| Ebitda | -7,065,451USD | -5,983,200USD | -9,222,758USD | -17,429,932USD | -13,223,560USD | -6,343,279USD | -2,827,359USD | -4,849,778USD |
| Depreciation And Amortization | 119,273USD | 186,049USD | 183,471USD | 118,188USD | 118,788USD | 57,563USD | 6,372USD | 188,372USD |
| Reconciled Depreciation | 119,273USD | 186,049USD | 183,471USD | 118,188USD | 118,788USD | 57,563USD | 4,779USD | 188,372USD |
| Total Other Income Expense Net | 726,843USD | 845,499USD | 849,143USD | 822,666USD | 10,338,982USD | 37,412USD | -309,445USD | 40,101USD |
| Selling And Marketing Expenses | — | — | 183,471USD | — | — | — | — | — |
| Interest Expense | — | — | — | 822,666USD | 116,931USD | 94,975USD | 56,840USD | 0USD |
| Net Income Applicable To Common Shares | — | — | — | -17,548,924USD | -13,343,150USD | -6,364,230USD | -3,141,583USD | -1,536,556USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q3 20262026-06-30 · USD | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 12,721,195USD | 12,384,738USD | 14,710,442USD | 13,661,518USD | 14,804,800USD | 16,454,299USD | 4,164,181USD | 3,813,982USD |
| Cash And Equivalents | 10,300,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 10,780,278USD | 10,417,727USD | 12,717,487USD | 11,512,876USD | 12,761,092USD | 14,387,289USD | 2,071,928USD | 1,675,622USD |
| Other Current Assets | 219,707USD | 197,576USD | 234,414USD | 77,838USD | 112,659USD | 108,199USD | 157,787USD | 367,394USD |
| Total Liabilities | 3,910,041USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 3,910,041USD | 2,187,921USD | 756,163USD | 1,078,536USD | 672,674USD | 914,701USD | 1,900,219USD | 1,832,827USD |
| Total Stockholder Equity | 8,811,154USD | 10,196,817USD | 13,954,279USD | 12,451,982USD | 14,132,126USD | 15,539,598USD | 2,263,962USD | 1,981,155USD |
| Total Equity Including Noncontrolling Interest | 8,811,154USD | — | — | — | — | — | — | — |
| Net Receivables | 228,051USD | 216,468USD | 431,325USD | 642,866USD | 286,743USD | 382,440USD | 350,639USD | 270,908USD |
| Accounts Payable | 3,910,041USD | — | — | — | 672,674USD | 914,701USD | 1,900,219USD | 1,812,960USD |
| Common Stock | 62,416,047USD | 58,932,825USD | 57,899,593USD | 54,515,421USD | 54,271,112USD | 54,271,112USD | 47,562,091USD | 47,236,024USD |
| Retained Earnings | -77,896,367USD | -72,451,359USD | -68,196,040USD | -65,910,974USD | -63,645,218USD | -61,858,769USD | -60,231,745USD | -58,589,013USD |
| Accumulated Other Comprehensive Income | -158,541USD | -186,089USD | -171,086USD | -165,771USD | -123,077USD | -287,688USD | -223,957USD | -242,613USD |
| Intangible Assets | — | 1,927,090USD | 1,952,383USD | 1,977,676USD | 2,002,969USD | 2,028,262USD | 2,053,555USD | 2,078,848USD |
| Total Liab | — | 2,187,921USD | 756,163USD | 1,209,536USD | 672,674USD | 914,701USD | 1,900,219USD | 1,832,827USD |
| Other Current Liab | — | 2,187,921USD | 756,163USD | 1,078,536USD | 672,674USD | 914,701USD | 1,900,219USD | 1,812,960USD |
| Capital Stock | — | 67,307,608USD | 67,197,186USD | 63,775,617USD | 63,493,910USD | 63,456,925USD | 48,543,265USD | 47,236,024USD |
| Cash | — | 10,003,683USD | 12,051,748USD | 10,792,172USD | 12,361,690USD | 13,896,650USD | 1,563,502USD | 1,037,320USD |
| Cash And Short Term Investments | — | 10,003,683USD | 12,051,748USD | 10,792,172USD | 12,361,690USD | 13,896,650USD | 1,563,502USD | 1,037,320USD |
| Net Debt | — | -10,003,683USD | -12,051,748USD | -10,792,172USD | -12,361,690USD | -13,896,650USD | -1,563,502USD | -1,017,453USD |
| Common Stock Shares Outstanding | — | 8,253,715shares | 7,972,532shares | 7,059,397shares | 7,022,678shares | 5,305,763shares | 3,345,135shares | 3,197,423shares |
| Non Current Assets Total | — | 1,967,011USD | 1,992,955USD | 2,148,641USD | 2,043,708USD | 2,067,010USD | 2,092,253USD | 2,138,360USD |
| Non Current Liabilities Total | — | 0USD | 0USD | 131,000USD | 0USD | 0USD | 0USD | 126,000USD |
| Non Currrent Assets Other | — | 39,921USD | 40,572USD | 170,965USD | 40,739USD | 38,748USD | 38,698USD | 41,151USD |
| Net Working Capital | — | 8,229,806USD | 11,961,324USD | 10,434,340USD | 12,088,418USD | 13,472,588USD | 171,709USD | -157,205USD |
| Unclassified Equity | — | -43,406,168USD | -42,775,374USD | -39,762,311USD | -39,864,601USD | -40,041,982USD | -33,385,692USD | -33,659,267USD |
| Property Plant Equipment Net | — | — | — | 0USD | 0USD | 0USD | 0USD | 18,361USD |
| Property Plant Equipment Gross | — | — | — | 0USD | 0USD | 0USD | 0USD | 70,909USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | -1,900,219USD | -1,812,960USD |
| Short Term Debt | — | — | — | — | — | — | — | 19,867USD |
| Short Long Term Debt Total | — | — | — | — | — | — | — | 19,867USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 13,530,518USD | 3,813,982USD | 8,890,437USD | 11,575,728USD | 14,584,655USD | 10,762,375USD | 5,717,764USD | 11,779,975USD |
| Intangible Assets | 1,977,676USD | 2,078,848USD | 2,180,020USD | 2,281,192USD | 2,382,364USD | 2,483,536USD | — | — |
| Other Current Assets | 77,838USD | 367,394USD | 448,912USD | 745,543USD | 948,645USD | 802,877USD | 397,022USD | 103,406USD |
| Total Liab | 1,078,536USD | 1,832,827USD | 1,841,637USD | 2,184,439USD | 1,526,364USD | 4,131,200USD | 461,634USD | 493,385USD |
| Total Stockholder Equity | 12,451,982USD | 1,981,155USD | 7,048,800USD | 9,391,289USD | 13,058,291USD | 6,631,175USD | 5,256,130USD | 11,286,590USD |
| Other Current Liab | 1,078,536USD | 1,812,960USD | 1,747,150USD | 2,121,802USD | 1,379,842USD | -68,269USD | 37,000USD | 493,385USD |
| Common Stock | 54,515,421USD | 47,236,024USD | 46,643,151USD | 42,473,099USD | 34,887,721USD | 18,500,853USD | 12,005,051USD | 56,652,957USD |
| Capital Stock | 63,775,617USD | 47,236,024USD | 46,643,151USD | 42,473,099USD | 34,887,721USD | 18,500,853USD | 12,005,051USD | 56,652,957USD |
| Retained Earnings | -65,910,974USD | -58,589,013USD | -52,418,968USD | -44,044,553USD | -26,495,629USD | -13,132,954USD | -6,734,615USD | -50,430,992USD |
| Cash | 10,792,172USD | 1,037,320USD | 5,361,397USD | 7,090,919USD | 7,839,259USD | 7,213,695USD | 5,030,583USD | 4,225,521USD |
| Cash And Short Term Investments | 10,792,172USD | 1,037,320USD | 5,361,397USD | 7,090,919USD | 7,839,259USD | 7,213,695USD | 5,030,583USD | 10,303,552USD |
| Total Current Assets | 11,512,876USD | 1,675,622USD | 6,436,852USD | 9,091,913USD | 12,090,731USD | 8,104,018USD | 5,644,706USD | 10,655,984USD |
| Total Current Liabilities | 1,078,536USD | 1,832,827USD | 1,821,864USD | 2,140,777USD | 1,458,650USD | 1,529,857USD | 461,634USD | 493,385USD |
| Net Debt | -10,792,172USD | -1,017,453USD | -5,266,910USD | -7,071,944USD | -7,739,939USD | -7,049,505USD | -5,030,583USD | -4,225,521USD |
| Net Receivables | 642,866USD | 270,908USD | 626,543USD | 1,255,451USD | 3,302,827USD | 87,446USD | 217,101USD | 41,246USD |
| Accounts Payable | 1,078,536USD | 1,812,960USD | 1,747,150USD | 2,121,802USD | 1,379,842USD | 1,460,127USD | 424,634USD | 493,385USD |
| Property Plant Equipment Net | 0USD | 18,361USD | 100,075USD | 31,159USD | 111,560USD | 174,821USD | 73,058USD | 1,062,195USD |
| Property Plant Equipment Gross | 0USD | 70,909USD | 143,921USD | 70,677USD | 145,413USD | 174,821USD | 73,058USD | 1,062,195USD |
| Accumulated Other Comprehensive Income | -165,771USD | -242,613USD | -214,648USD | -213,602USD | -205,262USD | -287,204USD | -342,074USD | 5,064,625USD |
| Common Stock Shares Outstanding | 5,676,708shares | 3,197,423shares | 2,858,928shares | 2,096,446shares | 1,725,403shares | 1,229,594shares | 655,318shares | 478,229shares |
| Non Current Assets Total | 2,017,642USD | 2,138,360USD | 2,453,585USD | 2,483,815USD | 2,493,924USD | 2,658,357USD | 73,058USD | 1,123,991USD |
| Non Current Liabilities Total | 131,000USD | 126,000USD | 19,773USD | 43,662USD | 67,714USD | 2,601,343USD | 0USD | 0USD |
| Non Currrent Assets Other | 39,966USD | 41,151USD | 173,490USD | 171,464USD | 0USD | — | 73,058USD | 15,340USD |
| Net Working Capital | 10,434,340USD | -157,205USD | 4,614,988USD | 6,951,136USD | 10,632,081USD | 6,574,161USD | 5,183,072USD | 10,162,599USD |
| Unclassified Current Liabilities | -1,078,536USD | -1,812,960USD | -1,747,150USD | -2,121,802USD | -1,379,842USD | — | — | — |
| Unclassified Equity | -39,762,311USD | -33,659,267USD | -33,603,886USD | -31,296,754USD | -30,016,260USD | -16,950,373USD | -11,677,283USD | -56,652,957USD |
| Short Term Debt | — | 19,867USD | 74,714USD | 18,975USD | 78,808USD | 139,460USD | — | — |
| Short Long Term Debt Total | — | 19,867USD | 94,487USD | 18,975USD | 99,320USD | 164,190USD | — | — |
| Current Deferred Revenue | — | — | -1,747USD | -2,121,802USD | -1,379,842USD | -1,460USD | — | — |
| Other Liab | — | — | — | 43,662USD | 47,202USD | 29,928USD | — | — |
| Other Assets | — | — | — | 0USD | 14,584,655USD | — | — | 15,340USD |
| Inventory | — | — | — | -1,255,451USD | — | -87,446USD | -217,101USD | 224,267USD |
| Net Tangible Assets | — | — | — | 7,110,097USD | 10,675,927USD | 4,147,639USD | 5,256,130USD | -2,849,523USD |
| Non Current Liabilities Other | — | — | — | — | 67,714USD | 124,388USD | — | — |
| Unclassified Non Current Assets | — | — | — | — | -14,584,655USD | — | — | — |
| Unclassified Non Current Liabilities | — | — | — | — | — | 2,447,027USD | — | — |
| Long Term Investments | — | — | — | — | — | — | — | 46,456USD |
| Short Term Investments | — | — | — | — | — | — | — | 6,078,031USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q3 20262026-06-30 · USD |
|---|---|
| Depreciation | 76,976USD |
| Stock Based Compensation | 1,432,178USD |
| Change To Liabilities | 2,910,348USD |
| Change In Working Capital | 2,765,237USD |
| Operating Cash Flow | -7,186,629USD |
| Financing Cash Flow | 6,793,376USD |
| Effect Of Forex Changes On Cash | -66,399USD |
| Change In Cash | -459,652USD |
| End Cash Flow | 10,332,520USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -4,218,332USD | -1,617,253USD | -2,228,358USD | -1,749,464USD | -1,590,448USD | -1,617,253USD | -962,051USD | -1,668,212USD |
| Depreciation | 25,872USD | 43,109USD | 25,868USD | 25,787USD | 24,509USD | 43,109USD | 44,206USD | 51,415USD |
| Stock Based Compensation | -81,183USD | 81,183USD | 404,425USD | 177,381USD | 66,653USD | 81,183USD | 93,933USD | 100,000USD |
| Other Non Cash Items | 438,485USD | -329,386USD | -44,549USD | -311,734USD | 105,187USD | -24,242USD | 75,638USD | 9,506USD |
| Change To Account Receivables | 214,939USD | 217,387USD | -359,828USD | 110,404USD | -29,215USD | -97,692USD | 284,489USD | 557,561USD |
| Change In Working Capital | 1,702,942USD | -264,987USD | 77,071USD | 107,032USD | -872,315USD | -24,242USD | -143,127USD | 650,812USD |
| Total Cash From Operating Activities | -2,051,033USD | -2,087,334USD | -1,765,543USD | -1,750,998USD | -2,333,067USD | -1,517,203USD | -967,039USD | -856,479USD |
| Capital Expenditures | -3USD | -4USD | -3USD | 0USD | -3USD | -3USD | 0USD | -4USD |
| Free Cash Flow | -2,051,030USD | -2,087,330USD | -1,765,540USD | -1,750,995USD | -2,333,070USD | -1,517,203USD | -967,039USD | -856,479USD |
| Total Cash From Financing Activities | 19,080USD | 3,355,419USD | 244,384USD | 216,924USD | 14,555,946USD | 2,071,545USD | -31,435USD | 106,025USD |
| Issuance Of Capital Stock | 0USD | 3,497,825USD | 220,501USD | 0USD | 15,210,373USD | 2,167,580USD | 0USD | 138,391USD |
| Change In Cash | -2,048,065USD | 1,259,576USD | -1,569,518USD | -1,534,960USD | 12,333,148USD | 526,182USD | -1,003,564USD | -758,747USD |
| Begin Period Cash Flow | 12,051,748USD | 10,792,172USD | 12,361,690USD | 13,896,650USD | 1,563,502USD | 1,037,320USD | 2,040,884USD | 2,799,631USD |
| End Period Cash Flow | 10,003,683USD | 12,051,748USD | 10,792,172USD | 12,361,690USD | 13,896,650USD | 1,563,502USD | 1,037,320USD | 2,040,884USD |
| Other Cashflows From Financing Activities | -28,060USD | — | — | -201,778USD | 8,556,924USD | 1,540,820USD | -2,789USD | 6,784USD |
| Net Borrowings | — | — | 0USD | 0USD | — | — | 0USD | 0USD |
| Unclassified Financing Cash Flow | — | — | — | — | -9,211,351USD | -1,636,855USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 4USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -7,185,523USD | -6,170,045USD | -8,374,415USD | -17,548,924USD | -13,343,150USD | -6,364,230USD | -2,776,734USD | -5,038,949USD |
| Depreciation | 119,273USD | 186,049USD | 183,471USD | 118,188USD | 118,788USD | 57,563USD | 4,779USD | 188,372USD |
| Stock Based Compensation | 729,642USD | 537,492USD | 1,246,457USD | 2,260,634USD | 3,195,469USD | 598,359USD | 46,508USD | 154,313USD |
| Change To Account Receivables | -377,987USD | 356,339USD | 562,770USD | 2,027,454,000USD | -3,229,954USD | 127,131USD | 9,737USD | -40,004USD |
| Change In Working Capital | -985,654USD | 571,065USD | 308,004USD | 2,890,800USD | -3,636,038USD | 721,968USD | -2,108,906USD | 13,042USD |
| Total Cash From Operating Activities | -7,322,262USD | -4,890,205USD | -6,636,483USD | -12,279,302USD | -13,664,931USD | -4,986,340USD | -4,845,787USD | -4,615,505USD |
| Capital Expenditures | 0USD | 0USD | -3USD | -5,656USD | -6,146USD | -34,339USD | -8,095USD | -382,810USD |
| Free Cash Flow | -7,322,262USD | -4,890,205USD | -6,636,483USD | -12,284,958USD | -13,671,077USD | -5,020,679USD | -4,853,882USD | -4,998,315USD |
| Net Borrowings | 0USD | -29,532USD | 0USD | — | 0USD | 29,748USD | 29,748USD | 29,748USD |
| Total Cash From Financing Activities | 17,030,898USD | 592,031USD | 4,830,111USD | 11,629,628USD | 14,174,740USD | 7,092,749USD | 7,092,749USD | 8,772,167USD |
| Issuance Of Capital Stock | 17,598,454USD | 729,387USD | 4,345,017USD | 11,957,687USD | 12,662,357USD | 4,360,500USD | — | 4,520,319USD |
| Change In Cash | 9,754,852USD | -4,324,077USD | -1,729,522USD | -748,340USD | 625,564USD | 2,183,112USD | 1,663,485USD | -345,430USD |
| Begin Period Cash Flow | 1,037,320USD | 5,361,397USD | 7,090,919USD | 7,839,259USD | 7,213,695USD | 5,030,583USD | 3,367,098USD | 4,570,951USD |
| End Period Cash Flow | 10,792,172USD | 1,037,320USD | 5,361,397USD | 7,090,919USD | 7,839,259USD | 7,213,695USD | 5,030,583USD | 4,225,521USD |
| Other Cashflows From Financing Activities | 9,880,820USD | -107,824USD | 485,094USD | -328,059USD | 1,512,384USD | 2,702,501USD | 6,417,968USD | 4,251,848USD |
| Unclassified Financing Cash Flow | -10,448,376USD | — | — | — | — | — | — | -4,680,409USD |
| Other Non Cash Items | — | -14,766USD | 308,004USD | 2,378,822USD | 3,314,257USD | 655,922USD | 2,753,455USD | 12,419USD |
| Investments | — | — | 41USD | -5,656USD | -6,146USD | 19,073USD | 6,417,968USD | -4,466,440USD |
| Other Cashflows From Investing Activities | — | — | -3USD | — | — | 23,929USD | 36,741USD | -4,083,630USD |
| Change To Liabilities | — | — | — | 882,843USD | -124,724USD | 998,903USD | -1,923,573USD | 79,040USD |
| Total Cashflows From Investing Activities | — | — | — | -5,656USD | -6,146USD | 19,073USD | 6,417,968USD | -4,466,440USD |
| Unclassified Operating Cash Flow | — | — | — | -2,378,822USD | -3,314,257USD | — | -2,764,889USD | — |
| Change To Inventory | — | — | — | — | — | 0USD | 77,913USD | -156,153USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | — | 9,170,980USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | 4,466,440USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.